Literature summary for 3.4.22.B5 extracted from

Zadeh-Vakili, A.; Taheri, T.; Taslimi, Y.; Doustdari, F.; Salmanian, A.H.; Rafati, S.
Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis (2004), Vaccine, 22, 1930-1940.

Search for more literature for 3.4.22.B5

Application

Application	Comment	Organism
medicine	the hybrid CPA/B is able to elicit a protective immune response against Leishmania major in the mice model	Leishmania major

Cloned(Commentary)

Cloned (Comment)	Organism
subcloned into pET-23a for expression in Escherichia coli BL21 (DE3) pLysS cells	Leishmania major

Organism

Organism	UniProt	Comment	Textmining
Leishmania major	-	-	-
Leishmania major MRHO/IR/75/ER	-	-	-

Purification (Commentary)

Purification (Comment)	Organism
SDS-PAGE	Leishmania major

Synonyms

Synonyms	Comment	Organism
CPB	-	Leishmania major
cysteine proteinase type I	-	Leishmania major

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)